01 1Aurobindo Pharma Limited
02 2Chemeca Drugs Private Limited
03 1Harman Finochem Limited
04 1Olon SpA
05 1Professional Compounding Centers of America dba PCCA
06 1Siegfried Evionnaz SA
07 1Solara Active Pharma Sciences Limited
08 1UQUIFA MEXICO, S.A. DE C.V.
01 1CARISOPRODOL
02 7Carisoprodol
03 1carisoprodol
01 5India
02 1Italy
03 1Spain
04 1Switzerland
05 1United Kingdom
NDC Package Code : 65862-260
Start Marketing Date : 2024-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 77777-112
Start Marketing Date : 2019-09-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 77777-112
Start Marketing Date : 2023-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 66064-5001
Start Marketing Date : 2008-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0406
Start Marketing Date : 2017-02-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-3169
Start Marketing Date : 2011-12-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 17381-080
Start Marketing Date : 2010-04-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 72643-017
Start Marketing Date : 1982-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52286-0021
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Carisoprodol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carisoprodol, including repackagers and relabelers. The FDA regulates Carisoprodol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carisoprodol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Carisoprodol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Carisoprodol supplier is an individual or a company that provides Carisoprodol active pharmaceutical ingredient (API) or Carisoprodol finished formulations upon request. The Carisoprodol suppliers may include Carisoprodol API manufacturers, exporters, distributors and traders.
click here to find a list of Carisoprodol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Carisoprodol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Carisoprodol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Carisoprodol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Carisoprodol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Carisoprodol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Carisoprodol suppliers with NDC on PharmaCompass.
We have 8 companies offering Carisoprodol
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
